Of South Africa’s nine health MECs, five are new
Following South Africa’s 2024 national and provincial elections, the decisions about the top health jobs in the country’s nine provinces have now all been made. Elri Voigt rounds up the appointments.
Following South Africa’s 2024 national and provincial elections, the decisions about the top health jobs in the country’s nine provinces have now all been made. Elri Voigt rounds up the appointments.
In some respects, Dr Aaron Motsoaledi was the right person for the job when he was appointed as South Africa’s Minister of Health in 2009. But in 2024, the healthcare context in the country looks very different. Spotlight editor Marcus Low asks what we might expect from this new chapter with Motsoaledi in the top health job.
Within South Africa’s beleaguered public health sector – unsettled by budget cuts, understaffing, and divisive NHI legislation – cutting edge surgical robots that have been used to perform more than 600 surgeries at two Cape Town public hospitals are beacons of excellence that offer a glimmer of hope. Spotlight’s Biénne Huisman visited Dr Tim Forgan at Tygerberg Hospital to learn more.
A trade unionist who spent years fighting for the rights of workers, the Free State‘s new health MEC Monyatso Mahlatsi now finds himself on the other side of the table where he might well be forced to make decisions that he would once have protested against. Refilwe Mochoari reports.
Eastern Cape Premier Oscar Mabuyane has appointed Ntandokazi Capa as the province’s new MEC for Health. Luvuyo Mehlwana asked Capa about her vision for healthcare in the province and rounds up some early responses to her appointment from healthcare unions and political parties.
A decade into South Africa’s HPV vaccination programme, the health department is switching from a two-dose to a single dose vaccine regimen and girls in private schools are set to start receiving government subsidised jabs. The vaccine provided, GlaxoSmithKline’s Cervarix, will remain the same. The move is backed by evidence showing one-dose regimens provide similar protection against HPV infection as multi-dose regimens. Catherine Tomlinson reports.
One of the biggest stories in HIV in the last year was that a class of medicines called statins could help reduce cardiovascular disease in people living with the virus. In response, treatment guidelines in the United States were quickly updated, but the picture is more complicated in South Africa. Spotlight’s Elri Voigt explores why the case for widespread use of statins by people living with HIV is less compelling in South Africa than in some other countries.
Gender-affirming healthcare for transgender youth has sparked intense debate globally. In South Africa, we need to significantly improve accessibility throughout the country, ensure services are well-resourced, include trained healthcare providers skilled in gender affirming care, and offer comprehensive care that integrates mental health and social services, write Jenna-Lee de Beer-Procter and Pierre Brouard, on behalf of fellow board members of the Professional Association for Transgender Health South Africa.
The South African Medical Association has for years raised concerns about the criminalisation of medical errors, stressing that current legal practices may undermine patient safety and deter doctors from performing high-risk procedures. Spotlight’s Thabo Molelekwa investigates.
HIV prevention injections have been registered for use in South Africa, but their high price and limited supply means that for the next few years, while awaiting more affordable generics, very few people will be able to get the jabs. In this Spotlight special briefing, Catherine Tomlinson looks at the difficult choices facing the country if we want to offer the injection to more people more quickly. The calls we make could have global implications.
By month end South Africa will have a new Minister of Health. Ufrieda Ho asked some academics and activists what qualities that person should have to tackle the key health issues the country faces.
Besides preventing illness and death, tuberculosis prevention therapy is estimated to be highly cost effective. Yet, uptake of the medication is not what it could be in South Africa. Tiyese Jeranji asks how much has changed since the Department of Health last year decided to make TB prevention therapy much more widely available.